Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
Department of Community Health Sciences, College of Medicine, University of Manitoba, Winnipeg, Canada.
Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1:68-77. doi: 10.1002/pds.4889. Epub 2019 Sep 10.
The Canadian Network for Observational Drug Effect Studies (CNODES) is a network of Canadian research centres using administrative data to conduct distributed drug safety and effectiveness studies. In this study, we compare the provincial administrative databases and illustrate the potential impact of database differences on a CNODES study about domperidone and the risk of ventricular tachyarrhythmia and sudden cardiac death (VT/SCD).
We assessed the impact of varying versions and precision of the International Classification of Diseases coding system in physician claims data, and the content and completeness of hospital discharge abstracts across CNODES sites, as these variations can introduce differences in the study cohorts formed and affect study results.
In our study of 214 962 patients, hospital diagnosis type (such as most responsible, admitting, or secondary diagnosis) was missing in some provinces, resulting in misclassification of the outcome and variation in rates and risk estimates. Incidence rates of VT/SCD ranged from 19.8 (95% confidence interval [CI] 17.7-22.2) per 10 000 person-years in British Columbia to 53.4 (95% CI 50.3-56.5) in Quebec. While most provinces reported an increased risk of VT/SCD, a null effect was observed in Quebec (rate ratio 1.06; 95% CI 0.79-1.41).
Distributed analyses allow for rapid responses to drug safety signals. However, variation in characteristics of the administrative data across research centres can influence study results. By identifying the sources of database heterogeneity, one can evaluate the potential biases these differences may introduce, highlighting the importance of considering such variation in distributed networks.
加拿大观察性药物效应研究网络(CNODES)是一个由加拿大研究中心组成的网络,利用行政数据进行分散的药物安全性和有效性研究。在这项研究中,我们比较了省级行政数据库,并说明了数据库差异对关于多潘立酮和室性心动过速/心搏骤停(VT/SCD)风险的 CNODES 研究的潜在影响。
我们评估了医生索赔数据中国际疾病分类系统的不同版本和精度以及 CNODES 站点之间的住院记录摘要的内容和完整性对研究队列形成的影响,因为这些差异可能会导致研究队列的差异,并影响研究结果。
在我们对 214962 名患者的研究中,一些省份缺少医院诊断类型(如主要责任、入院或次要诊断),导致结局分类错误,发生率和风险估计值发生变化。VT/SCD 的发生率范围从不列颠哥伦比亚省的每 10000 人年 19.8(95%置信区间 [CI] 17.7-22.2)到魁北克省的 53.4(95%CI 50.3-56.5)。虽然大多数省份报告 VT/SCD 的风险增加,但在魁北克省观察到无显著影响(率比 1.06;95%CI 0.79-1.41)。
分布式分析允许对药物安全性信号做出快速反应。然而,研究中心之间行政数据的特征差异可能会影响研究结果。通过确定数据库异质性的来源,可以评估这些差异可能引入的潜在偏差,突出考虑分布式网络中此类差异的重要性。